Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 23 Sep 2024 08:30 CEST |
SYENSQO | Syensqo - Participation notification by BlackRock Inc. | 55101000 Diversified Materials | Change in Capital |
| 23 Sep 2024 08:30 CEST |
ALTERNUS ENERGY GROUP PLC | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | 65101010 Alternative Electricity | Announcement from Oslo Børs |
| 23 Sep 2024 08:30 CEST |
BARRAMUNDI GROUP LTD. | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | 45102010 Farming, Fishing, Ranching and Plantations | Announcement from Oslo Børs |
| 23 Sep 2024 08:30 CEST |
- | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | - | Announcement from Oslo Børs |
| 23 Sep 2024 08:30 CEST |
SYENSQO | Syensqo - Notification de participation par BlackRock Inc. | 55101000 Diversified Materials | Change in Capital |
| 23 Sep 2024 08:30 CEST |
EAM SOLAR AS | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | 30202000 Diversified Financial Services | Announcement from Oslo Børs |
| 23 Sep 2024 08:30 CEST |
Nova Austral S.A. | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | - | Announcement from Oslo Børs |
| 23 Sep 2024 08:30 CEST |
Solis Bond Company 21/24 FRN EUR FLOOR C | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | - | Announcement from Oslo Børs |
| 23 Sep 2024 08:29 CEST |
- | OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH | - | Announcement from Oslo Børs |
| 23 Sep 2024 08:25 CEST |
HSBCFRN10MAY27 | HSBC CONTINENTAL EUROPE : CESSION DES ACTIVITES DE BANQUE PRIVEE DE HSBC EN ALLEMAGNE | - | Other subject |
| 23 Sep 2024 08:25 CEST |
HSBCFRN10MAY27 | HSBC Continental Europe: Sale of Private Banking Business of HSBC in Germany | - | Other subject |
| 23 Sep 2024 08:19 CEST |
BlueNord ASA | Major Holding Notification | 60101010 Oil: Crude Producers | Major shareholding notifications |
| 23 Sep 2024 08:15 CEST |
AGEAS | Ageas annonce son nouveau plan stratégique triennal : Elevate27 | 30301010 Life Insurance | Other financial transaction |
| 23 Sep 2024 08:15 CEST |
AGEAS | Ageas kondigt zijn nieuwe driejarig strategisch plan aan: Elevate27 | 30301010 Life Insurance | Other financial transaction |
| 23 Sep 2024 08:15 CEST |
AGEAS | Ageas announces its new three-year strategic plan: Elevate27 | 30301010 Life Insurance | Other financial transaction |
| 23 Sep 2024 08:13 CEST |
TOTALENERGIES | Air France-KLM Ramps Up Its SAF Offtake Agreement with TotalEnergies, Which Will Supply Up to 1.5 Million Tons of More Sustainable Aviation Fuel Over a 10-Year Period | 60101000 Integrated Oil and Gas | Other subject |
| 23 Sep 2024 08:13 CEST |
TOTALENERGIES | Air France-KLM revoit à la hausse son accord d’achat de carburant d’aviation plus durable avec TotalEnergies, qui lui fournira jusqu’à 1,5 million de tonnes de SAF sur 10 ans | 60101000 Integrated Oil and Gas | Other subject |
| 23 Sep 2024 08:10 CEST |
EXOR | Exor Press Release - Periodic Report on the Buyback Program | 30202000 Diversified Financial Services | Other financial transaction |
| 23 Sep 2024 08:00 CEST |
Storebrand ASA | STOREBRAND ASA: Status tilbakekjøp av egne aksjer | 30301010 Life Insurance | Utsteders meldeplikt ved handel i egne aksjer |
| 23 Sep 2024 08:00 CEST |
BOA CONCEPT | BOA CONCEPT: Webinaire investisseurs le 23 septembre 2024 | 50204000 Machinery: Industrial | Meetings / events |
| 23 Sep 2024 08:00 CEST |
Storebrand ASA | STOREBRAND ASA: Status share buyback program | 30301010 Life Insurance | Acquisition or disposal of the issuer’s own shares |
| 23 Sep 2024 08:00 CEST |
Sparebanken Sør | Sparebanken Sør: Vurderer utstedelse av ansvarlig lån | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 23 Sep 2024 08:00 CEST |
Sparebanken Sør | Sparebanken Sør: Contemplating issuance of Tier 2 bonds | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2024 08:00 CEST |
PUBLIC PROPERTY INVEST ASA | Mandatory Notification of Trade | 35101010 Real Estate Holding and Development | Mandatory notification of trade primary insiders |
| 23 Sep 2024 08:00 CEST |
NORSK HYDRO ASA | Norsk Hydro: Invitation to Hydro's Capital Markets Day, London | 55102035 Aluminum | Non-regulatory press releases |
| 23 Sep 2024 08:00 CEST |
NORSK HYDRO ASA | Norsk Hydro: Invitasjon til Hydros kapitalmarkedsdag i London | 55102035 Aluminum | Ikke-informasjonspliktige pressemeldinger |
| 23 Sep 2024 08:00 CEST |
HAV GROUP ASA | HAV Group ASA: Subsidiary to deliver battery package to Rem Offshore CSV | 50206030 Marine Transportation | Non-regulatory press releases |
| 23 Sep 2024 08:00 CEST |
MEDINCELL S.A. | Medincell’s Partner Teva Provided Treatment Insights into Switching to UZEDY® from Perseris® | 20103010 Biotechnology | New |
| 23 Sep 2024 08:00 CEST |
Bane NOR Eiendom AS | Contemplating senior unsecured green bond issuance | - | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Sep 2024 08:00 CEST |
BOOSTHEAT | ÉVOLUTION DU CACRE JURIDIQUE ET DE LA VALEUR NOMINALE | 60102020 Renewable Energy Equipment | Legal |
| 23 Sep 2024 08:00 CEST |
MEDINCELL S.A. | Teva, partenaire de Medincell, a présenté de nouvelles données d'efficacité, de sécurité et de tolérance de l’essai pivot de phase 3 de l'olanzapine LAI pour les patients adultes atteints de schizophrénie | 20103010 Biotechnology | New |
| 23 Sep 2024 08:00 CEST |
MEDINCELL S.A. | Teva, partenaire de Medincell, a présenté de nouvelles données soutenant la transition de Perseris® à UZEDY® pour le traitement de la schizophrénie | 20103010 Biotechnology | New |
| 23 Sep 2024 08:00 CEST |
HAV GROUP ASA | HAV Group ASA: Datterselskap skal levere batteripakke til Rem Offshore CSV | 50206030 Marine Transportation | Ikke-informasjonspliktige pressemeldinger |
| 23 Sep 2024 08:00 CEST |
ECIT AS B-AKSJER | ECIT AS interim H1 results 2024 | 50205020 Professional Business Support Services | Half yearly financial reports and audit reports/limited reviews |
| 23 Sep 2024 08:00 CEST |
NORWEGIAN BLOCK EXCHANGE AS | Endringer i styresammensetning | 30202015 Investment Services | Annen informasjonspliktig regulatorisk informasjon |
| 23 Sep 2024 08:00 CEST |
MEDINCELL S.A. | Medincell’s Partner Teva Presented New Efficacy, Safety, and Tolerability Data from Pivotal Phase 3 of Olanzapine LAI for Adult Patients Diagnosed with Schizophrenia | 20103010 Biotechnology | New |
| 23 Sep 2024 07:31 CEST |
SENSORION | Sensorion Announces the Availability of its Half Year 2024 Report | 20103010 Biotechnology | New |
| 23 Sep 2024 07:31 CEST |
SENSORION | Sensorion annonce la mise à disposition de son Rapport du 1er semestre 2024 | 20103010 Biotechnology | New |
| 23 Sep 2024 07:30 CEST |
NICOX S.A. | Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement | 20103015 Pharmaceuticals | News contracts |
| 23 Sep 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
| 23 Sep 2024 07:30 CEST |
SENSORION | Sensorion Reports New Positive Clinical Results Presented at the World Congress of Audiology | 20103010 Biotechnology | New |
| 23 Sep 2024 07:30 CEST |
GENFIT | GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine | 20103010 Biotechnology | Other subject |
| 23 Sep 2024 07:30 CEST |
NICOX S.A. | Nicox et Glaukos signent un accord exclusif de recherche incluant une option de licence mondiale pour NCX 1728 | 20103015 Pharmaceuticals | News contracts |
| 23 Sep 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
| 23 Sep 2024 07:30 CEST |
SENSORION | Sensorion annonce de nouveaux résultats cliniques positifs présentés lors du Congrès Mondial d'Audiologie | 20103010 Biotechnology | New |
| 23 Sep 2024 07:30 CEST |
GENFIT | GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval | 20103010 Biotechnology | Other subject |
| 23 Sep 2024 07:02 CEST |
Aker ASA | Aker ASA: Mandatory Notification of Trade | 30202000 Diversified Financial Services | Mandatory notification of trade primary insiders |
| 23 Sep 2024 07:00 CEST |
Stadshypotek AB (publ) | Ledningsförändring i Handelsbanken | - | Annen informasjonspliktig regulatorisk informasjon |
| 23 Sep 2024 07:00 CEST |
AKER BP | Employees buy shares in Aker BP | 60101010 Oil: Crude Producers | Mandatory notification of trade primary insiders |
| 23 Sep 2024 07:00 CEST |
Stadshypotek AB (publ) | Management changes at Handelsbanken | - | Additional regulated information required to be disclosed under the laws of a Member State |